Innate Pharma SA (IPH)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
€1.922
Buy
€1.97
€-0.038 (-1.92%)
Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in developing immunotherapy drugs for cancer and inflammatory diseases.
Prices updated at 02 Jun 2025, 16:40 BST
| Prices minimum 15 mins delay
|
Prices in EUR
-0.14%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Share price chart
Please note that past performance is not a reliable indicator of future returns.